医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ClearSight Announces Sale of Parent Company, Sharklet Technologies

2017年05月22日 PM11:00
このエントリーをはてなブックマークに追加


 

AURORA, Colo.

ClearSight LLC is pleased to announce the acquisition of its parent company Sharklet Technologies, Inc., by Peaceful Union, an equity medical device firm in Hangzhou, China. ClearSight LLC was co-founded by Drs. Kevin Cuevas and Shravanthi Reddy to develop the next generation intraocular lens (IOL) implant.

“We believe that the biomimetic approach used by Sharklet Technologies will not only produce the most advanced IOL, but will most likely enhance the performance of a wide range of ophthalmic products,” said Dr. Khalid “Kal” Mentak, CEO of ClearSight, LLC.

For more information see: www.clearsightiol.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20170522005319/en/

CONTACT

ClearSight
Shravanthi Reddy, COO
805-350-8216
sreddy@clearsightiol.com

同じカテゴリーの記事 

  • AriBio 获得欧洲药品管理局对AR1001治疗阿尔茨海默病3期临床试验(POLARIS-AD)的授权
  • AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)
  • ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続
  • ReNAgade Therapeutics继续致力于GanNA Bio和糖生物学的研究
  • ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology